Journal of Pharmacy and Pharmacology · 1986 · 10 citations · 22 references
MedicineNeurobiologyPharmacologyNeurochemistryNeuropharmacologyPharmacodynamicsNeurotransmissionNeurotransmitter SystemsSerotonergic PharmacologySerotonergic Signaling5-Hydroxytryptamine Receptor PharmacologyPharmacology Of Serotonergic AgentsSerotonin PharmacodynamicsVas Deferens Anatomy
5-Hydroxytryptamine (5-HT) slightly inhibited the twitch contractions of rat vas deferens caused by single pulse field stimulation at 0.1 Hz. The inhibitory effect of 5-HT was much less in the epididymal portion than in the prostatic portion of the vas deferens. Ketanserin potentiated the prejunctional inhibitory effect of 5-HT and attenuated its stimulatory effect. This potentiation was observable only in the epididymal portion, of the vas deferens. Cyproheptadine and mianserin, but not methysergide, had essentially similar potentiating effects to those of ketanserin. These results suggest that the 5-HT receptor that mediates prejunctional inhibition is not of the 5-HT2 type, and that ketanserin acts by suppressing the 5-HT-induced stimulatory effect, which is possibly mediated by a postjunctional 5-HT2 receptor, thus unmasking the inhibitory effect of 5-HT.
22
J E Leysen, C. J. E. Niemegeers, Jan M. Van Nueten et al. · Molecular Pharmacology · 1982 · 1.1K citations
G. Engel, M. G�thert, Else M�ller-Schweinitzer et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1983 · 203 citations